Dermatology
Latest News
Long-term maintenance required in melasma patients
To optimize results following the laser treatment of melasma, Dr. Arisa Ortiz uses one application of clobetasol immediately after the procedure...
Latest News
Topical treatment options for acne continue to expand
IDP-126 is a fixed dose triple combination of clindamycin 1.2% plus benzoyl peroxide 3.1% and adapalene 0.15% is being evaluated in patients nine...
Latest News
New treatments aim to tame vitiligo
Topical ruxolitinib offers another tool to try, with strong safety and efficacy.
Latest News
Oral minoxidil improves anticancer treatment–induced alopecia in women with breast cancer
Oral minoxidil has been receiving increased attention as an adjunctive therapy for hair loss, particularly for women.
Latest News
Adverse events linked to better survival with ICIs in melanoma
“We feel these findings will help clinicians in discussions with patients and in clinical decision-making after adverse events develop,” one of...
Latest News
Topical psoriasis treatments
When using topical treatments, combination therapy is generally more effective than monotherapy for psoriasis, especially for plaque psoriasis, Dr...
Latest News
Study evaluates features of alopecia areata in Hispanic/Latinx patients
The authors found that 18% of patients had one or more coexisting autoimmune conditions, most commonly rheumatoid arthritis and thyroid disease....
News from the FDA/CDC
FDA approves Idacio as eighth adalimumab biosimilar in U.S.
Data for Idacio (adalimumab-aacf) showed safety, efficacy, and immunogenicity similar to Humira.
From the Journals
Ustekinumab matches TNF inhibitors for psoriatic arthritis in 3-year, real-world study
A real-world study comparing the interleukin-12/23 inhibitor ustekinumab with tumor necrosis factor inhibitors for psoriatic arthritis found...
Latest News
Melanoma mortality rates fell in 2010s as new therapies took hold
Immunotherapy and targeted therapy appear to be paying dividends, new study finds.
Latest News
Subset of patients with melanoma have very low mortality risk
The authors were interested in identifying lesions that are currently diagnosed as melanoma but might lack the capacity for metastasis.